These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37922934)

  • 21. Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.
    Galldiks N; Niyazi M; Grosu AL; Kocher M; Langen KJ; Law I; Minniti G; Kim MM; Tsien C; Dhermain F; Soffietti R; Mehta MP; Weller M; Tonn JC
    Neuro Oncol; 2021 Jun; 23(6):881-893. PubMed ID: 33538838
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Deuschl C; Kirchner J; Poeppel TD; Schaarschmidt B; Kebir S; El Hindy N; Hense J; Quick HH; Glas M; Herrmann K; Umutlu L; Moenninghoff C; Radbruch A; Forsting M; Schlamann M
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):593-601. PubMed ID: 29282517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis.
    Fountain DM; Bryant A; Barone DG; Waqar M; Hart MG; Bulbeck H; Kernohan A; Watts C; Jenkinson MD
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013630. PubMed ID: 33428222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.
    Tropeano MP; Raspagliesi L; Bono BC; Baram A; Rossini Z; Franzini A; Navarria P; Clerici E; Bellu L; Simonelli M; Scorsetti M; Riva M; Politi LS; Pessina F
    Acta Neurochir (Wien); 2024 Apr; 166(1):196. PubMed ID: 38676720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraoperative imaging technology to maximise extent of resection for glioma.
    Jenkinson MD; Barone DG; Bryant A; Vale L; Bulbeck H; Lawrie TA; Hart MG; Watts C
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012788. PubMed ID: 29355914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical Management of Recurrent Intracranial Gliomas.
    Ferguson SD; Momin EN; Weinberg JS
    Prog Neurol Surg; 2018; 30():218-231. PubMed ID: 29241177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical Management and Advances in the Treatment of Glioma.
    Hardigan AA; Jackson JD; Patel AP
    Semin Neurol; 2023 Dec; 43(6):810-824. PubMed ID: 37963582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulvinar Locus is Highly Relevant to Patients' Outcomes in Surgically Resected Thalamic Gliomas in Children.
    Chiba K; Aihara Y; Masui K; Abe K; Komori T; Kawamata T
    World Neurosurg; 2020 Feb; 134():e530-e539. PubMed ID: 31704359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Ryken TC; Parney I; Buatti J; Kalkanis SN; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):551-83. PubMed ID: 26530266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
    PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of [
    Roach JR; Plaha P; McGowan DR; Higgins GS
    J Neurooncol; 2022 Dec; 160(3):577-589. PubMed ID: 36434486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria.
    Sharma M; Juthani RG; Vogelbaum MA
    Chin Clin Oncol; 2017 Aug; 6(4):37. PubMed ID: 28841799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
    Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentric Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients with Low-Grade Gliomas: The LoG-Glio Project.
    Pala A; Nadji-Ohl M; Faust K; Rückriegel S; Roder C; von der Brelie C; Forster MT; Löbel F; Schommer S; Löhr M; Renovanz M; Grübel N; Rothenbacher D; König R; Engelke J; Schmitz B; Wirtz CR; Ringel F; Senft C; Rohde V; Tatagiba M; Ernestus RI; Vajkoczy P; Ganslandt O; Nagel G; Coburger J
    J Neurol Surg A Cent Eur Neurosurg; 2020 Jan; 81(1):48-57. PubMed ID: 31550737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
    Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
    Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
    Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of high functional connectivity network hub resection on language task performance in adult low- and high-grade glioma.
    Lee AT; Faltermeier C; Morshed RA; Young JS; Kakaizada S; Valdivia C; Findlay AM; Tarapore PE; Nagarajan SS; Hervey-Jumper SL; Berger MS
    J Neurosurg; 2021 Mar; 134(3):1102-1112. PubMed ID: 32244221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
    Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.